ResMed Inc. (RSMDF)
OTCMKTS
· Delayed Price · Currency is USD
30.00
+18.09 (151.89%)
Apr 17, 2025, 4:00 PM EDT
ResMed Revenue
ResMed had revenue of $1.28B in the quarter ending December 31, 2024, with 10.26% growth. This brings the company's revenue in the last twelve months to $4.93B, up 9.38% year-over-year. In the fiscal year ending June 30, 2024, ResMed had annual revenue of $4.69B with 10.95% growth.
Revenue (ttm)
4.93B
Revenue Growth
+9.38%
P/S Ratio
6.33
Revenue / Employee
493.66K
Employees
9,980
Market Cap
31.21B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 4.69B | 462.30M | 10.95% |
| Jun 30, 2023 | 4.22B | 644.87M | 18.02% |
| Jun 30, 2022 | 3.58B | 381.30M | 11.93% |
| Jun 30, 2021 | 3.20B | 239.81M | 8.11% |
| Jun 30, 2020 | 2.96B | 350.44M | 13.44% |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
| Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SS Innovations International | 20.65M |
| Endo Inc. | 1.76B |
| Veradigm | 588.02M |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 200.90M |
| Northwest Biotherapeutics | 1.38M |
| BioStem Technologies | 210.49M |
| American Oncology Network | 1.76B |
ResMed News
- 15 days ago - Resmed Announces Small, Easy to Use Home Sleep Apnea Test, NightOwl™, Now Available Across the US - GlobeNewsWire
- 16 days ago - Resmed to Report Third Quarter Fiscal 2025 Earnings on April 23, 2025 - GlobeNewsWire
- 17 days ago - My Top 15 High-Growth Dividend Stocks For April 2025 - Seeking Alpha
- 4 weeks ago - Lightning Round: Stay away from aluminum, says Jim Cramer - CNBC
- 4 weeks ago - New Global Study Finds: Sleep Apnea Patients Who Use CPAP Live Longer - GlobeNewsWire
- 5 weeks ago - Resmed Unveils Unified Brand to Lead the Global Sleep and Health Technology Revolution - GlobeNewsWire
- 5 weeks ago - ResMed Among Top Stocks For Recent And Long-Term Profit Growth - Investor's Business Daily
- 6 weeks ago - Insider Sell Alert: Peter Farrell Sells 2,000 Shares of ResMed Inc (RMD) - GuruFocus